DSS, Inc. (DSS)
| Market Cap | 6.71M |
| Revenue (ttm) | 25.02M |
| Net Income (ttm) | -64.32M |
| Shares Out | 7.07M |
| EPS (ttm) | -9.12 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,699 |
| Open | 0.970 |
| Previous Close | 0.980 |
| Day's Range | 0.950 - 0.970 |
| 52-Week Range | 0.900 - 3.080 |
| Beta | 1.75 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2024 |
About DSS
DSS, Inc. operates in the product packaging, biotechnology, commercial lending, securities and investment management, alternative trading, and direct marketing businesses. It manufactures, markets, and sells mailers, photo sleeves, custom folding cartons, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. The company also invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the advancement of drug discovery and prevention, inhibiti... [Read more]
Financial Performance
In 2023, DSS, Inc.'s revenue was $30.26 million, a decrease of -36.04% compared to the previous year's $47.31 million. Losses were -$80.61 million, 34.7% more than in 2022.
Financial StatementsNews
DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value
NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a dedicated supporter and investor in Impact BioMedical Inc. (NYSE American: IBO), is delighted to announce the successful ...
AmericaFirst Funds Trust Announces Changes to Board of Trustees
NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- AmericaFirst Funds, a subsidiary of DSS, Inc. (NYSE American: DSS), today announced that effective August 9, 2024, David Friedensohn, Monica Himes and Alla...
DSS, Inc. Names Jason Grady as Interim Chief Executive Officer
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) has announced the appointment of Jason Grady as its Interim CEO, effective August 23, 2024. Grady, who previously served as C...
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."
NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Lae...
DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market
Chairman of the Board Heng Fai Ambrose Chan Adds 672,173 Shares to Increase Investment in Company Chairman of the Board Heng Fai Ambrose Chan Adds 672,173 Shares to Increase Investment in Company
DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS, “Company”), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to...
Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years
NEW YORK, Nov. 28, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shar...
DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder's Common Stock
DSS Shareholders to Benefit from Reduction in Common Stock of Impact Biomedical DSS Shareholders to Benefit from Reduction in Common Stock of Impact Biomedical
DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing Rule
Company intends to cure the deficiency and return to compliance with NYSE American standard Company intends to cure the deficiency and return to compliance with NYSE American standard
DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical
NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) -- DSS, Inc.(NYSE American: DSS) ("DSS") announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commissio...
DSS Inc. Issues Letter to Shareholders
CEO Highlights Expected IPO of Impact Biomedical and Progress in Subsidiaries CEO Highlights Expected IPO of Impact Biomedical and Progress in Subsidiaries
DSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management Subsidiary
Jim Monaghan Appointed Chief Operating Officer and Chief Compliance Officer; Michael Cheah Joins as Portfolio Manager and Head of Fixed Income Jim Monaghan Appointed Chief Operating Officer and Chief ...
DSS Inc. Announces Distribution Date of August 8, 2023 for Spinoff of Impact BioMedical Inc.
DSS Shareholders of Record on July 10, 2023 to Receive Four Shares of Impact Biomedical Inc. for Every One Share of DSS, Inc. DSS Shareholders of Record on July 10, 2023 to Receive Four Shares of Impa...
DSS Inc. Appoints Daniel Lew as Chief Investment Officer and Portfolio Manager for DSS Wealth, Inc.
ROCHESTER, N.Y., July 05, 2023 (GLOBE NEWSWIRE) -- DSS Wealth, Inc., a wholly owned subsidiary of DSS, Inc. and advisor to DSS AmericaFirst Quantitative Funds, is pleased to announce the appointment o...
DSS Inc. Announces Updated Shareholder of Record Date for Spinoff of Impact BioMedical Inc.
Shareholders of Record on July 10, 2023 to Receive Four Shares of Impact Biomedical Inc. for Every One Share of DSS, Inc. on a Future Distribution Date Shareholders of Record on July 10, 2023 to Recei...
DSS, Inc. Announces Record and Distribution Date for Impact Biomedical Spin-Off Special Dividend
DSS Shareholders of Record on June 30 to Receive 4 Shares for Every 1 DSS Share DSS Shareholders of Record on June 30 to Receive 4 Shares for Every 1 DSS Share
DSS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
ROCHESTER, N.Y., May 16, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions and ...
DSS Inc. Announces Distribution Date of Sharing Services Shares to DSS Shareholders
Distribution Date of May 4, 2023 Set for Stock Dividend of Sharing Services Shares (SHRG) Distribution Date of May 4, 2023 Set for Stock Dividend of Sharing Services Shares (SHRG)
DSS, Inc. Announces Plan to Distribute Common Stock of Sharing Services Global Corporation to Shareholders
ROCHESTER, N.Y., April 19, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions an...
DSS, Inc. to Present at Emerging Growth Conference April 19 at 1:45 PM
Company to Highlight Strong Revenue Growth and Planned Spinoffs to DSS Shareholders Company to Highlight Strong Revenue Growth and Planned Spinoffs to DSS Shareholders
DSS Announces Letter to Shareholders
CEO Highlights Business Plan including Spin-Offs CEO Highlights Business Plan including Spin-Offs
DSS Receives New York Stock Exchange Notice Regarding Late Form 10-Q Filing
ROCHESTER, N.Y., Aug. 30, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets ...
DSS Announces Licensing of Impact BioMedical's Linebacker Portfolio to ProPhase Labs
ROCHESTER, N.Y., July 21, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets ...
DSS Strengthens and Expands Board with Appointment of Two Independent Directors
ROCHESTER, N.Y., July 13, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets ...
Impact BioMedical Announces License Agreement with ProPhase Labs to Produce and Distribute Viral-Fighting Compound Equivir
HENRIETTA, N.Y., June 28, 2022 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc., a wholly owned subsidiary of DSS, Inc. (NYSE American: DSS), along with its scientific research partner Global Research and ...